Androgenetic
alopecia (AGA) is the medical name for the commonest form
of hair loss affecting both men and women. It affects around
50% of men and between 20% - 50 % of women by the age of
50.
AGA is caused by progressive,
gradual shrinking of normal hair follicles that produce normal
(terminal) hairs into miniturised hair follicles that produce
fine (vellus) hairs. The terminal-to-vellus hair ratio, normally
2:1 gradually reduces until it is reversed.
Although AGA is considered
by most doctors to be a cosmetic condition, it can have significant
psychological and physical effects on those affected by it.
Loss of hair allows increased ultraviolet light to reach the
scalp. AGA has also been linked to prostrate and cardiac conditions
in older men. Women are particularly prone to suffering the
adverse psychological effects of hairloss, as a thick head
of hair is a highly valued aspect of feminine beauty in almost
every culture.
AGA occurs most commonly
in Caucasian men, followed by Asian and African American men.
AGA has it’s lowest incidence in Native American and
Eskimo men.
Almost all men and women
with AGA begin to loose their hair prior to the age of 40
and many will commence loosing their hair by the age of 30.
AGA is distinguished from
all other types of Alopecia by it’s gradual onset.
Men present with gradual
thinning in the temporal areas, producing a V shaped frontal
hairline. As baldness progresses, a bald patch appears on
the crown of the head, which increases in size as the frontal
hairline recedes. Eventually the receeding frontal hairline
and the bald patch meet up, leading to loss of hair on most
of the top of the head, whilst the hair around the base of
the head remains intact. This pattern of hair loss is classified
by doctors as Norwood/Hamilton stages 1-7.
Women usually present with
diffuse thinning of hair on the crown of the head. This pattern
of hair loss is classified by doctors as Ludwig stages 1-3.
V shaped temporal recession does occur in women but usually
to a lesser degree than in men. In general, women maintain
their frontal hairline.
AGA is inherited however,
the exact mechanism of inheritance has not been determined.
It is also likely that systemic or external factors play a
role.
Topical Minoxidil
Solution 5%
Minoxidil is the only clinically proven way to stimulate
hair regrowth. Minoxidol stimulates the production
of fine (vellus) hairs in the scalp. Although the exact mechanism
of action is unknown, topical Minoxidil solution appears
to lengthen the duration of the anagen (growth) phase of
hair, and it may increase the blood supply to the follicle.
Minoxidil is used for the treatment of hereditary hair loss
(AGA) in men and women.
Used alone, regrowth is
more pronounced on the crown than in the frontal scalp and
is not noted for at least 4 months. Consequently, many people
grow discouraged and give up using topical Minoxidil solution
before it has had a chance to work.
The Clearskincare Skin & Scalp
Roller offers an effective and affordable
way to maximise the beneficial results of topical Minoxidil
solution. Best of all, results can be achieved within 4-6
weeks with daily scalp rolling and a single application of
topical Minoxidil solution.
Treatment with topical
Minoxidil solution and the Clearskincare Skin & Scalp
Roller is necessary indefinitely
as stopping treatment leads to reversion to the pretreatment
balding pattern.
Clearskincare Hair Tonic CP
Clearskincare CP Hair Tonic using 2nd generation copper peptides and soothing aloe vera, revitalises your hair and scalp, restoring and promoting your hairs sheen and lustre, adds body to your hair to look fuller, thicker and be more manageable.
Women with AGA
In women with AGA, especially
those with a component of hyperandrogenism drugs that act
as androgen suppressants (eg, spironolactone and oral contraceptives)
may be beneficial.
Surgical
treatment of AGA has been performed for the past 4 decades
via Hair Transplantation. The main problem is covering the
bald area with sufficient donor plugs to produce a normal
hair pattern. Micrografting produces a more natural appearance
than the old technique of transplanting plugs. Scalp reduction
has been attempted to decrease the size of the scalp to be
covered by transplanted hair. However, the scars produced
by the reduction technique often spread and become more noticeable
with time.
Ideally, if treatment with
the Clearskincare Hair Restoration Programme in combination
with minoxidil is commenced as soon as hair loss becomes
apparent, the need for Surgical treatment can be prevented.
Clearskincare Hair
Restoration Programme
Non surgical hair regrowth
with Clearskincare Skin & Scalp Roller, Clearskincare
CP Hair Tonic and Minoxidil.
How
does it work?
The Clearskincare Skin & Scalp
Roller (needle
length 0.75mm, gauge 0.25mm) has 96 finest quality
stainless steel needles mounted in the highest quality autoclavable
medical grade plastic rollers and handle. Used
daily and cared for as directed your Clearskincare
Skin & Scalp Roller will last for 12 months. The
Clearskincare Skin & Scalp Roller has three separate
actions on the scalp. The needles are designed to penetrate
the stratum corneum, the hard outer surface of the epidermal
layer of the scalp. Hundreds of tiny channels are created
through the stratum corneum, which facilitate the passage
and absorption of Minoxidil and Clearskincare CP Hair Tonic
into the dermis to maximize it’s
absorption by the hair follicles.
The Clearskincare Skin & Scalp
Roller also
stimulates blood flow to the hair follicles via direct scalp
massage. The third action of the Hair Restoration Scalp Roller
is to gently exfoliate excess skin cells which accumulate
in the hair follicles, contributing to hair follicle malnutrition
and ultimately hair follicle failure and permanent hair loss.
Our 96 needle Clearskincare Skin & Scalp
Roller is twice the width of the 48 needle roller. Therefore,
the amount of time you spend rolling is cut in half!
Does
it hurt?
The needles of the Clearskincare Skin & Scalp Roller
are long enough to assist in the penetration of Minoxidil
and Clearskincare CP Hair Tonic, but will not damage the
scalp in anyway. It is normal for the scalp to be a little
sensitive when scalp rolling is first commenced, but most
people report no problems after 1 week. Always use the Clearskincare’s
Skin & Scalp
Roller gently at first, increasing the pressure on the roller
as you become accustomed to the sensation of scalp rolling.
Can
the Clearskincare Skin & Scalp Roller be used
for women and as well as men?
Definitely. Women can use the Clearskincare Skin & Scalp
Roller with Clearskincare CP Hair Tonic or in conjunction
with Minoxidil.
How long will my
Clearskincare Skin & Scalp Roller last?
Used daily and cared for as directed your Clearskincare
Skin & Scalp Roller will last for 12 months. The Clearskincare
Skin & Scalp Roller is the only roller available worldwide
that is designed to be reusable and to last for 12 months.
Are there any side effects?
Unlike many other hair loss treatments, which require oral
supplements with unknown potential side effects, the Clearskincare
Skin & Scalp Roller does exactly what it promises, by
enhancing the penetration of Minoxidil and Clearskincare
CP Hair Tonic and improving blood flow to the scalp and hair
follicle.
How is success measured for improving
AGA by combining the Clearskincare Skin & Scalp Roller
in combination with Minoxidil?
For 85% of clients, their alopecia is stabilised, they do
not continue to lose more hair. 64% of these clients whose
alopecia is stabilised, will get new hair growth. 15% of
clients will continue to lose hair and the alopecia continues
to deteriorate.
How can I obtain Minoxidil? Minoxidil can be readily obtained
from pharmacies in Australia and throughout the world. If
you need any assistance in obtaining Minoxidil, please contact
Clearskincare via consultation@clearskincare.com.au If you
have any questions about the Clearskincare Skin & Scalp Roller
or hair loss please contact Clearskincare at consultation@clearskincare.com.au
It is recommended the Clearskincare Skin & Scalp Roller
is used by one person only.
